The global mRNA Vaccine And Therapeutics market was valued at US$ 36680 million in 2023 and is anticipated to reach US$ 51630 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030.

mRNA Vaccine And Therapeutics Market

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for mRNA Vaccine And Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccine And Therapeutics.

Report Scope

The mRNA Vaccine And Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Vaccine And Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the mRNA Vaccine And Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of mRNA Vaccine And Therapeutics Market Report

Report Metric	Details
Report Name	mRNA Vaccine And Therapeutics Market
Accounted market size in 2023	US$ 36680 million
Forecasted market size in 2030	US$ 51630 million
CAGR	4.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Infectious Disease Cancer Others
Segment by Application	Hospital Research Institual
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Argos Therapeutics, BioNTech, CureVac, eTheRNA, Ethris, In-Cell-Art, Moderna Therapeutics, Sangamo Therapeutics, Tiba Biotechnology, Translate Bio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Vaccine And Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is mRNA Vaccine And Therapeutics Market growing?

Ans: The mRNA Vaccine And Therapeutics Market witnessing a CAGR of 4.9% during the forecast period 2024-2030.

What is the mRNA Vaccine And Therapeutics Market size in 2030?

Ans: The mRNA Vaccine And Therapeutics Market size in 2030 will be US$ 51630 million.

Who are the main players in the mRNA Vaccine And Therapeutics Market report?

Ans: The main players in the mRNA Vaccine And Therapeutics Market are Argos Therapeutics, BioNTech, CureVac, eTheRNA, Ethris, In-Cell-Art, Moderna Therapeutics, Sangamo Therapeutics, Tiba Biotechnology, Translate Bio

What are the Application segmentation covered in the mRNA Vaccine And Therapeutics Market report?

Ans: The Applications covered in the mRNA Vaccine And Therapeutics Market report are Hospital, Research Institual

What are the Type segmentation covered in the mRNA Vaccine And Therapeutics Market report?

Ans: The Types covered in the mRNA Vaccine And Therapeutics Market report are Infectious Disease, Cancer, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Infectious Disease

1.2.3 Cancer

1.2.4 Others

1.3 Market by Application

1.3.1 Global mRNA Vaccine And Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Research Institual

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global mRNA Vaccine And Therapeutics Market Perspective (2019-2030)

2.2 mRNA Vaccine And Therapeutics Growth Trends by Region

2.2.1 Global mRNA Vaccine And Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 mRNA Vaccine And Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 mRNA Vaccine And Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 mRNA Vaccine And Therapeutics Market Dynamics

2.3.1 mRNA Vaccine And Therapeutics Industry Trends

2.3.2 mRNA Vaccine And Therapeutics Market Drivers

2.3.3 mRNA Vaccine And Therapeutics Market Challenges

2.3.4 mRNA Vaccine And Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top mRNA Vaccine And Therapeutics Players by Revenue

3.1.1 Global Top mRNA Vaccine And Therapeutics Players by Revenue (2019-2024)

3.1.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global mRNA Vaccine And Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by mRNA Vaccine And Therapeutics Revenue

3.4 Global mRNA Vaccine And Therapeutics Market Concentration Ratio

3.4.1 Global mRNA Vaccine And Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by mRNA Vaccine And Therapeutics Revenue in 2023

3.5 mRNA Vaccine And Therapeutics Key Players Head office and Area Served

3.6 Key Players mRNA Vaccine And Therapeutics Product Solution and Service

3.7 Date of Enter into mRNA Vaccine And Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 mRNA Vaccine And Therapeutics Breakdown Data by Type

4.1 Global mRNA Vaccine And Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Type (2025-2030)

5 mRNA Vaccine And Therapeutics Breakdown Data by Application

5.1 Global mRNA Vaccine And Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America mRNA Vaccine And Therapeutics Market Size (2019-2030)

6.2 North America mRNA Vaccine And Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America mRNA Vaccine And Therapeutics Market Size by Country (2019-2024)

6.4 North America mRNA Vaccine And Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe mRNA Vaccine And Therapeutics Market Size (2019-2030)

7.2 Europe mRNA Vaccine And Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe mRNA Vaccine And Therapeutics Market Size by Country (2019-2024)

7.4 Europe mRNA Vaccine And Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific mRNA Vaccine And Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific mRNA Vaccine And Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America mRNA Vaccine And Therapeutics Market Size (2019-2030)

9.2 Latin America mRNA Vaccine And Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America mRNA Vaccine And Therapeutics Market Size by Country (2019-2024)

9.4 Latin America mRNA Vaccine And Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa mRNA Vaccine And Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Argos Therapeutics

11.1.1 Argos Therapeutics Company Detail

11.1.2 Argos Therapeutics Business Overview

11.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Introduction

11.1.4 Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.1.5 Argos Therapeutics Recent Development

11.2 BioNTech

11.2.1 BioNTech Company Detail

11.2.2 BioNTech Business Overview

11.2.3 BioNTech mRNA Vaccine And Therapeutics Introduction

11.2.4 BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.2.5 BioNTech Recent Development

11.3 CureVac

11.3.1 CureVac Company Detail

11.3.2 CureVac Business Overview

11.3.3 CureVac mRNA Vaccine And Therapeutics Introduction

11.3.4 CureVac Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.3.5 CureVac Recent Development

11.4 eTheRNA

11.4.1 eTheRNA Company Detail

11.4.2 eTheRNA Business Overview

11.4.3 eTheRNA mRNA Vaccine And Therapeutics Introduction

11.4.4 eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.4.5 eTheRNA Recent Development

11.5 Ethris

11.5.1 Ethris Company Detail

11.5.2 Ethris Business Overview

11.5.3 Ethris mRNA Vaccine And Therapeutics Introduction

11.5.4 Ethris Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.5.5 Ethris Recent Development

11.6 In-Cell-Art

11.6.1 In-Cell-Art Company Detail

11.6.2 In-Cell-Art Business Overview

11.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Introduction

11.6.4 In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.6.5 In-Cell-Art Recent Development

11.7 Moderna Therapeutics

11.7.1 Moderna Therapeutics Company Detail

11.7.2 Moderna Therapeutics Business Overview

11.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Introduction

11.7.4 Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.7.5 Moderna Therapeutics Recent Development

11.8 Sangamo Therapeutics

11.8.1 Sangamo Therapeutics Company Detail

11.8.2 Sangamo Therapeutics Business Overview

11.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Introduction

11.8.4 Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.8.5 Sangamo Therapeutics Recent Development

11.9 Tiba Biotechnology

11.9.1 Tiba Biotechnology Company Detail

11.9.2 Tiba Biotechnology Business Overview

11.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Introduction

11.9.4 Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.9.5 Tiba Biotechnology Recent Development

11.10 Translate Bio

11.10.1 Translate Bio Company Detail

11.10.2 Translate Bio Business Overview

11.10.3 Translate Bio mRNA Vaccine And Therapeutics Introduction

11.10.4 Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2019-2024)

11.10.5 Translate Bio Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Infectious Disease

Table 3. Key Players of Cancer

Table 4. Key Players of Others

Table 5. Global mRNA Vaccine And Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global mRNA Vaccine And Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global mRNA Vaccine And Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global mRNA Vaccine And Therapeutics Market Share by Region (2019-2024)

Table 9. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global mRNA Vaccine And Therapeutics Market Share by Region (2025-2030)

Table 11. mRNA Vaccine And Therapeutics Market Trends

Table 12. mRNA Vaccine And Therapeutics Market Drivers

Table 13. mRNA Vaccine And Therapeutics Market Challenges

Table 14. mRNA Vaccine And Therapeutics Market Restraints

Table 15. Global mRNA Vaccine And Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global mRNA Vaccine And Therapeutics Market Share by Players (2019-2024)

Table 17. Global Top mRNA Vaccine And Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine And Therapeutics as of 2023)

Table 18. Ranking of Global Top mRNA Vaccine And Therapeutics Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by mRNA Vaccine And Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players mRNA Vaccine And Therapeutics Product Solution and Service

Table 22. Date of Enter into mRNA Vaccine And Therapeutics Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global mRNA Vaccine And Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2019-2024)

Table 26. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2025-2030)

Table 28. Global mRNA Vaccine And Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global mRNA Vaccine And Therapeutics Revenue Market Share by Application (2019-2024)

Table 30. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global mRNA Vaccine And Therapeutics Revenue Market Share by Application (2025-2030)

Table 32. North America mRNA Vaccine And Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America mRNA Vaccine And Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America mRNA Vaccine And Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe mRNA Vaccine And Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe mRNA Vaccine And Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe mRNA Vaccine And Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific mRNA Vaccine And Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America mRNA Vaccine And Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America mRNA Vaccine And Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America mRNA Vaccine And Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa mRNA Vaccine And Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 47. Argos Therapeutics Company Detail

Table 48. Argos Therapeutics Business Overview

Table 49. Argos Therapeutics mRNA Vaccine And Therapeutics Product

Table 50. Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 51. Argos Therapeutics Recent Development

Table 52. BioNTech Company Detail

Table 53. BioNTech Business Overview

Table 54. BioNTech mRNA Vaccine And Therapeutics Product

Table 55. BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 56. BioNTech Recent Development

Table 57. CureVac Company Detail

Table 58. CureVac Business Overview

Table 59. CureVac mRNA Vaccine And Therapeutics Product

Table 60. CureVac Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 61. CureVac Recent Development

Table 62. eTheRNA Company Detail

Table 63. eTheRNA Business Overview

Table 64. eTheRNA mRNA Vaccine And Therapeutics Product

Table 65. eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 66. eTheRNA Recent Development

Table 67. Ethris Company Detail

Table 68. Ethris Business Overview

Table 69. Ethris mRNA Vaccine And Therapeutics Product

Table 70. Ethris Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 71. Ethris Recent Development

Table 72. In-Cell-Art Company Detail

Table 73. In-Cell-Art Business Overview

Table 74. In-Cell-Art mRNA Vaccine And Therapeutics Product

Table 75. In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 76. In-Cell-Art Recent Development

Table 77. Moderna Therapeutics Company Detail

Table 78. Moderna Therapeutics Business Overview

Table 79. Moderna Therapeutics mRNA Vaccine And Therapeutics Product

Table 80. Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 81. Moderna Therapeutics Recent Development

Table 82. Sangamo Therapeutics Company Detail

Table 83. Sangamo Therapeutics Business Overview

Table 84. Sangamo Therapeutics mRNA Vaccine And Therapeutics Product

Table 85. Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 86. Sangamo Therapeutics Recent Development

Table 87. Tiba Biotechnology Company Detail

Table 88. Tiba Biotechnology Business Overview

Table 89. Tiba Biotechnology mRNA Vaccine And Therapeutics Product

Table 90. Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 91. Tiba Biotechnology Recent Development

Table 92. Translate Bio Company Detail

Table 93. Translate Bio Business Overview

Table 94. Translate Bio mRNA Vaccine And Therapeutics Product

Table 95. Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2019-2024) & (US$ Million)

Table 96. Translate Bio Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

List of Figures

Figure 1. Global mRNA Vaccine And Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global mRNA Vaccine And Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Infectious Disease Features

Figure 4. Cancer Features

Figure 5. Others Features

Figure 6. Global mRNA Vaccine And Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global mRNA Vaccine And Therapeutics Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Research Institual Case Studies

Figure 10. mRNA Vaccine And Therapeutics Report Years Considered

Figure 11. Global mRNA Vaccine And Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global mRNA Vaccine And Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global mRNA Vaccine And Therapeutics Market Share by Region: 2023 VS 2030

Figure 14. Global mRNA Vaccine And Therapeutics Market Share by Players in 2023

Figure 15. Global Top mRNA Vaccine And Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine And Therapeutics as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by mRNA Vaccine And Therapeutics Revenue in 2023

Figure 17. North America mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America mRNA Vaccine And Therapeutics Market Share by Country (2019-2030)

Figure 19. United States mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe mRNA Vaccine And Therapeutics Market Share by Country (2019-2030)

Figure 23. Germany mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific mRNA Vaccine And Therapeutics Market Share by Region (2019-2030)

Figure 31. China mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America mRNA Vaccine And Therapeutics Market Share by Country (2019-2030)

Figure 39. Mexico mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa mRNA Vaccine And Therapeutics Market Share by Country (2019-2030)

Figure 43. Turkey mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia mRNA Vaccine And Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Argos Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 46. BioNTech Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 47. CureVac Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 48. eTheRNA Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 49. Ethris Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 50. In-Cell-Art Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 51. Moderna Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 52. Sangamo Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 53. Tiba Biotechnology Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 54. Translate Bio Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2019-2024)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Gene Test Service Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-37C5753

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Electrophoretic Transmissometer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-24D14445

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Nucleic Acid Vaccine Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-10U8455

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Sequencing Gene Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-22G18536

Wed Dec 11 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions